USE OF MITOXANTHRONE TO OBTAIN A MEDICINAL PRODUCT FOR DIAGNOSTICS AND TREATMENT OF DISEASE ASSOCIATED WITH THYROIDECTOMY Russian patent published in 2024 - IPC A61K49/00 

Abstract RU 2817199 C1

FIELD: medicine.

SUBSTANCE: use of mitoxantrone in the preparation of a medicinal product for the diagnostics and treatment of a disease associated with thyroidectomy, and the use of mitoxantrone and/or a pharmaceutically acceptable salt thereof in the preparation of a lymphatic tracer for preventing false staining of the parathyroid glands, preventing false cutting of the parathyroid glands, or reducing the incidence of false cutting of the parathyroid glands. Local injection of mitoxantrone hydrochloride injection liquid will not cause erroneous staining of the parathyroid glands and can reduce the incidence of erroneous cutting of the parathyroid glands, thereby protecting the parathyroid glands well; besides, no local or systemic toxic side effects were observed after local injection.

EFFECT: invention is characterized by good tolerability, efficacy and safety and offers a comprehensive new idea in the radical treatment of thyroid diseases in patients suffering from diseases associated with thyroidectomy.

48 cl, 8 tbl, 11 ex

Similar patents RU2817199C1

Title Year Author Number
PHARMACEUTICAL COMPOSITION OF KAPPA OPIOID RECEPTOR AGONIST 2019
  • Tong Xinyong
  • Zou Aifeng
  • Zhou Yin
  • Fan Yi
  • Tao Weikang
RU2768482C1
PHARMACEUTICAL COMPOSITION INCLUDING DORSOLAMIDE AND BRIMONIDINE 2017
  • Umezaki, Shinya
RU2745317C2
COMPOSITION AND A METHOD OF TREATMENT OF DIABETES 2020
  • Sun, Taolei
RU2801902C1
USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME 2021
  • Li Chunlej
  • Lyu Yanpin
  • Van Tsajsya
  • Du Yanlin
  • Van Syaoyan
  • Shen Syuein
  • Van Shisya
  • Sun Shanshan
RU2821030C1
PHARMACEUTICAL COMPOSITION BASED ON ANTIBODIES AGAINST CD40 AND APPLICATION THEREOF 2019
  • Yang, Jianjian
  • Li, Hao
  • Liu, Xun
  • Jiang, Jiahua
RU2778572C1
PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO SOST, AND ITS USE 2018
  • Fang Jingjing
  • Yan Zhen
  • Liu Xun
RU2779430C2
PHARMACEUTICAL COMPOSITION OF THE FUSION PROTEIN OF THE TRANSFORMING GROWTH FACTOR BETA RECEPTOR AND ITS APPLICATION 2019
  • Tyan, Chenmin
  • Li, Khao
  • Lyu, Syun
RU2791683C2
ANTICANCER DRUG FOR THYROID CANCER 2007
  • Matsui Dzundzi
RU2448708C2
ANTIALLERGIC PHARMACEUTICAL COMPOSITION FOR LOCAL OCULAR APPLICATION AND METHOD FOR ITS PRODUCTION 1994
  • Khitosi Okhmori[Jp]
  • Takakhiro Ogava[Jp]
  • Fuminori Tokumoti[Jp]
  • Atsusi Okumura[Jp]
RU2107497C1
N-QUINOLYL- OR ISOQUINOLYL-SUBSTITUTED PURINE DERIVATIVES, METHODS FOR PREPARING AND USING THEREOF 2006
  • Vu Chzhanguj
RU2417230C2

RU 2 817 199 C1

Authors

Liu, Jun

Li, Xun

Yang, Zhanao

Tu, Feina

Chen, Ning

Huang, Quanhua

Liang, Huacheng

Lai, Baolin

Zhang, Weiwei

Dates

2024-04-11Published

2021-03-23Filed